Astra Tech moves into new building

March 2009
Proofs;Mar2009, Vol. 92 Issue 2, p77
Trade Publication
The article reports on the relocation of Astra Tech Inc. to its headquarter facility in Waltham, Massachusetts. The move has reportedly brought corporate operations and manufacturing of their Atlantis abutment solutions under one facility. The growth of the company in 2008 reportedly coincided with the acquisition of Atlantis Components Inc. The facility is said to be in close proximity to its sister company AstraZeneca.


Related Articles

  • PR pitch could portend AZ buy. M. A. // Medical Marketing & Media;Aug2011, Vol. 46 Issue 8, p24 

    The article reports that Astrazeneca has been reviewing its financial public relations (PR) business in Great Britain amid media speculation on the possible acquisitions run in the U.S.

  • It's official: Dentsply to acquire Astra Tech for $1.8 billion. FORD, OMAR // Medical Device Daily;6/23/2011, Vol. 15 Issue 116, p1 

    The article reports on the decision of AstraZeneca to sell its Astra Tech dental company to Dentsply for 1.8 billion dollars. According to Dentsply, the acquisition will give the firm stronger access into the medical device market and will possibly become a strong cash flow generator for the...

  • Atlantis bought by Astra Tech for $71 million.  // Medical Device Daily;9/28/2007, Vol. 11 Issue 186, p2 

    The article reports on the acquisition of Atlantis Components by Astra Tech for $71 million in cash. The deal will increase Atlantis' market penetration of the dental market. Atlantis CEO Bob Stockard said Astra Tech is the perfect owner of Atlantis as it offers the ideal environment within...

  • Merger forms largest ag-chem business in world. Stahl, Jason // Landscape Management;Jan2000, Vol. 39 Issue 1, p22 

    Announces that AstraZeneca PLC and Novartis AG have unveiled a merger and spinoff of their agricultural-chemical business. Potential stock market value of the merged company to be called Syngenta; Why Novartis chose to combine with AstraZeneca; Implication of the merger on the agrochemical industry.

  • (2) Pfizer Said to Have Held Talks to Buy AstraZeneca.  // MondayMorning;4/28/2014, Vol. 22 Issue 16, p2 

    The article reports on the interest of pharmaceutical corporation Pfizer in acquiring biopharmaceutical firm AstraZeneca PLC which saw a decline in its profit to $1.95 billion from 2.32 billion in the first quarter of 2013.

  • AstraZeneca Rejects Final Pfizer Bid.  // Contract Pharma;Jun2014, Vol. 16 Issue 5, p16 

    The article reports that the final offer of pharmaceutical company Pfizer Inc. for a merger was rejected by biopharmaceutical company AstraZeneca PLC.

  • $100 Mil. Pharmaceutical Media Business in Play. Feuer, Jack // Adweek Southeast Edition;08/28/2000, Vol. 21 Issue 35, p3 

    Deals with the media buying consolidation plans of prescription drug marketer, AstraZeneca Pharmaceuticals. Factor that prompted company decision for consolidation search; Number of drugs marketed by AstraZeneca; List of media companies included on its consolidation review; Sales growth posted...

  • EC to Investigate AZ-Novartis Merger. Milmo, Sean // Chemical Market Reporter;03/27/2000, Vol. 257 Issue 13, p8 

    Reports on the decision of the European Commission to investigate the proposed merger of the crop-protection business of AstraZeneca company and Novartis. Purpose of the commission for the investigation.

  • Where the Boss Used To Be. McKnight, Marshall // Business News New Jersey;01/09/2001, Vol. 14 Issue 2, p9 

    Reports on the merger deals between New Jersey-based corporate headquarters and out-of-state companies in 2000. Economic drain on the state's resources; Major deals in the banking sector; Food companies targeted for merger; Reasons why out-of-state corporations come to the state. INSETS: SOME...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics